Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis
Authors:
- Florian KurthFKFlorian Kurth
- Sabine BélardSBSabine Bélard
- Michael RamharterMichael Ramharter
- 1 February 2010
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 10 (2) , 125-132
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western KenyaMalaria Journal, 2008
- Alternative form of artemether-lumefantrine for infantsThe Lancet, 2008
- Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialThe Lancet, 2008
- Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in GabonThe Journal of Infectious Diseases, 2008
- Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in GabonJournal of Antimicrobial Chemotherapy, 2007
- PEDIATRIC MORTALITY IN AFRICA: PLASMODIUM FALCIPARUM MALARIA AS A CAUSE OR RISK?The American Journal of Tropical Medicine and Hygiene, 2004
- Antimalarial combinationsThe Lancet, 2004
- Fluid Management of Severefalciparum Malaria in African ChildrenTropical Doctor, 2004
- Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin®) in Cambodian children and adults with malariaBritish Journal of Clinical Pharmacology, 2003
- Efficacy and Safety of Dihydroartemisinin‐Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum MalariaClinical Infectious Diseases, 2002